Skip to main contentSkip to navigationSkip to search

EASL 2026

Efficacy and safety of CAM2029 in patients with polycystic liver disease: phase 2b POSITANO study_oral

Click the material you wish to view

See all posters presented at
EASL 2026

Explore more

Disease areas

Camurus is committed to improving treatment outcomes and quality of life for people with severe and chronic diseases.

Congresses

Discover Camurus’ engagement at conducted and upcoming international medical conferences and events.